241 related articles for article (PubMed ID: 38229014)
21. IDH1
Han X; Zhou H; Sun W; Hou L; Wang Y; Wang H; Lv Z; Xue X
Sci Rep; 2023 Nov; 13(1):19659. PubMed ID: 37952042
[TBL] [Abstract][Full Text] [Related]
22. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
23. Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.
Yuan F; Yi L; Hai L; Wang Y; Yang Y; Li T; Tong L; Ma H; Liu P; Ming H; Ren B; Yu S; Lin Y; Yang X
Dis Markers; 2019; 2019():7049294. PubMed ID: 31772693
[TBL] [Abstract][Full Text] [Related]
24. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
[No Abstract] [Full Text] [Related]
25. DNAJC1 facilitates glioblastoma progression by promoting extracellular matrix reorganization and macrophage infiltration.
Zhang H; Zheng W; Chen X; Sa L; Huo Y; Zhang L; Shan L; Wang T
J Cancer Res Clin Oncol; 2024 Jun; 150(6):315. PubMed ID: 38909166
[TBL] [Abstract][Full Text] [Related]
26. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
27. DGCR5 suppresses the EMT of pediatric primary glioblastoma multiforme cell and serves as a prognostic biomarker.
Yang F; Huang YL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10024-10034. PubMed ID: 31799672
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
[TBL] [Abstract][Full Text] [Related]
29. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
[TBL] [Abstract][Full Text] [Related]
30. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
31. Chromobox 7/8 serve as independent indicators for glioblastoma
Zheng ZQ; Yuan GQ; Kang NL; Nie QQ; Zhang GG; Wang Z
Front Neurol; 2022; 13():912039. PubMed ID: 36034290
[TBL] [Abstract][Full Text] [Related]
32. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
33. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
34. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p/HMGB3 axis.
Chen WL; Jiang L; Wang JS; Liao CX
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10874-10885. PubMed ID: 31858556
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
Feng F; Zhao Z; Cai X; Heng X; Ma X
Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
[TBL] [Abstract][Full Text] [Related]
36. Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Cheng S; Wang LY; Wang CH; Wang FK; Zhu B; Zhang P; Wang GH
Neuroreport; 2021 Apr; 32(6):507-517. PubMed ID: 33788813
[TBL] [Abstract][Full Text] [Related]
37. CSNK1D is associated with stemness and invasiveness in glioblastoma.
Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M
Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821
[TBL] [Abstract][Full Text] [Related]
38. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
39. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
[TBL] [Abstract][Full Text] [Related]
40. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma.
Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J
Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
